Showing posts with label transhumanism. Show all posts
Showing posts with label transhumanism. Show all posts

Monday, November 24, 2008

New Longevity Drugs Coming Soon?


From Wired.com

Cancer, diabetes, Alzheimer's, Parkinson's, heart disease: All have stubbornly resisted billions of dollars of research conducted by the world's finest minds. But they all may finally be defied by a single new class of drugs, a virtual cure for the diseases of aging.

In labs across the country, researchers are developing several new drugs that target the cellular engines called mitochondria. The first, resveratrol, is already in clinical trials for diabetes. It could be on the market in four years and used off-label as an all-purpose longevity enhancer. Other drugs promise to be more potent and refined. They might even be cheap.

"It's going to revolutionize western medicine," said Doug Wallace, a pioneer of mitochondrial medicine at the University of California at Irvine. "All the things that are common for an aging society, and nobody worried ...

Read the rest of the story

Thursday, August 28, 2008

Super Soldier Program

Maybe we can join the military when we turn 70 and get rejuvenated, like in Old Man's War.

We are investing billions into a super soldier program, which is seeking to achieve transhumanism within a few decades. Gene therapy also holds some great promise to enable average people to gain the ability to perform at or above human maximum.

Tuesday, July 15, 2008

Respirocytes: A Mechanical Articificial Red Blood Cell

Respirocytes are hypothetical robotic red blood cells that, if injected into the bloodstream, would allow humans to do an Olympic sprint for 15 minutes without taking a breath or sit at the bottom of a swimming pool for hours at a time.
Abstract: Molecular manufacturing promises precise control of matter at the atomic and molecular level, allowing the construction of micron-scale machines comprised of nanometer-scale components. Medical nanomachines will be among the earliest applications. The artificial red blood cell or "respirocyte" proposed here is a bloodborne spherical 1-micron diamondoid 1000-atm pressure vessel with active pumping powered by endogenous serum glucose, able to deliver 236 times more oxygen to the tissues per unit volume than natural red cells and to manage carbonic acidity. An onboard nanocomputer and numerous chemical and pressure sensors enable complex device behaviors remotely reprogrammable by the physician via externally applied acoustic signals. Primary applications will include transfusable blood substitution; partial treatment for anemia, perinatal/neonatal and lung disorders; enhancement of cardiovascular/neurovascular procedures, tumor therapies and diagnostics; prevention of asphyxia; artificial breathing; and a variety of sports, veterinary, battlefield and other uses.